Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current antihypertensive treatment: can we do better?

G Mancia1, C Giannattasio, G Grassi

  • 1Cattedra di Clinica Medica, University of Milan-Bicocca, San Gerardo Hospital, Milan, Italy. mancia.g@imiucca.csi.unimi.it

American Journal of Hypertension
|December 22, 1999
PubMed
Summary

Antihypertensive treatment significantly reduces cardiovascular, cerebrovascular, and renal disease risks. Focusing on systolic blood pressure control offers greater benefits for high-risk patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in severe outcomes in SARS-CoV-2-positive hospitalized patients with rheumatic diseases: a monocentric observational and case-control study in northern Italy.

Reumatismo·2023
Same author

Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management.

ESMO open·2021
Same author

Functional Improvement After Outpatient Cardiac Rehabilitation in Acute Coronary Syndrome Patients is Not Related to Improvement in Left Ventricular Ejection Fraction.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2020
Same author

Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2020
Same author

THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS.

European journal of internal medicine·2020
Same author

Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2017

Area of Science:

  • Cardiology
  • Nephrology
  • Neurology

Background:

  • Elevated blood pressure is a major risk factor for cardiovascular, cerebrovascular, and renal diseases.
  • Clinical trials demonstrate significant reductions in morbidity and mortality with antihypertensive treatment.
  • Benefits extend to conditions like cognitive decline and dementia.

Purpose of the Study:

  • To review the benefits of antihypertensive treatment.
  • To emphasize the importance of systolic blood pressure control.
  • To explore the role of pulse pressure and new therapies.

Main Methods:

  • Review of randomized, controlled clinical trials.
  • Analysis of epidemiological findings on blood pressure and cardiovascular risk.
  • Evaluation of prognostic value of pulse pressure.

Related Experiment Videos

Main Results:

  • Antihypertensive treatment reduces cardiovascular, cerebrovascular, and renal disease.
  • Systolic blood pressure (SBP) may be a greater risk factor than diastolic blood pressure (DBP).
  • Rigorous blood pressure control in high-risk patients yields greater benefits.

Conclusions:

  • Antihypertensive therapy offers substantial protection against major diseases.
  • Increased attention to systolic blood pressure control is warranted.
  • New monotherapies targeting SBP could enhance current hypertension management.